beta-lactamases exist
β-內醯胺酶存在
detecting beta-lactamases
檢測β-內醯胺酶
beta-lactamase production
β-內醯胺酶產生
beta-lactamases inhibit
β-內醯胺酶抑制
clinical beta-lactamases
臨床β-內醯胺酶
beta-lactamase genes
β-內醯胺酶基因
beta-lactamases degrade
β-內醯胺酶降解
beta-lactamase activity
β-內醯胺酶活性
beta-lactamases spread
β-內醯胺酶擴散
beta-lactamase testing
β-內醯胺酶檢測
the study investigated the prevalence of beta-lactamases in clinical isolates.
這項研究調查了臨床分離株中β-內醯胺酶的盛行率。
emerging beta-lactamase variants pose a significant threat to antibiotic efficacy.
新興的β-內醯胺酶變異體對抗生素的療效構成重大威脅。
patients with infections caused by beta-lactamase-producing bacteria require alternative therapies.
由產生β-內醯胺酶的細菌引起的感染患者需要替代療法。
rapid detection of beta-lactamases is crucial for guiding antibiotic stewardship programs.
快速檢測β-內醯胺酶對於指導抗生素管理方案至關重要。
carbapenemase beta-lactamases are particularly concerning due to their broad spectrum of activity.
碳青黴烯酶類β-內醯胺酶因其廣譜活性而特別令人擔憂。
researchers are developing novel inhibitors to overcome beta-lactamase resistance.
研究人員正在開發新型抑制劑以克服β-內醯胺酶的抗藥性。
the presence of extended-spectrum beta-lactamases (esbls) is a growing public health concern.
廣譜β-內醯胺酶（ESBLs）的存在正成為日益增長的公共衛生問題。
beta-lactamase genes are often located on mobile genetic elements, facilitating their spread.
β-內醯胺酶基因通常位於可移動的遺傳元件上，促進其傳播。
clinical laboratories routinely screen for beta-lactamases in bacterial isolates.
臨床實驗室通常會對細菌分離株進行β-內醯胺酶的篩查。
the increased incidence of beta-lactamase production necessitates new diagnostic approaches.
β-內醯胺酶產生的增加需要新的診斷方法。
understanding beta-lactamase mechanisms is essential for developing effective antibiotics.
了解β-內醯胺酶的機制對於開發有效的抗生素至關重要。
beta-lactamases exist
β-內醯胺酶存在
detecting beta-lactamases
檢測β-內醯胺酶
beta-lactamase production
β-內醯胺酶產生
beta-lactamases inhibit
β-內醯胺酶抑制
clinical beta-lactamases
臨床β-內醯胺酶
beta-lactamase genes
β-內醯胺酶基因
beta-lactamases degrade
β-內醯胺酶降解
beta-lactamase activity
β-內醯胺酶活性
beta-lactamases spread
β-內醯胺酶擴散
beta-lactamase testing
β-內醯胺酶檢測
the study investigated the prevalence of beta-lactamases in clinical isolates.
這項研究調查了臨床分離株中β-內醯胺酶的盛行率。
emerging beta-lactamase variants pose a significant threat to antibiotic efficacy.
新興的β-內醯胺酶變異體對抗生素的療效構成重大威脅。
patients with infections caused by beta-lactamase-producing bacteria require alternative therapies.
由產生β-內醯胺酶的細菌引起的感染患者需要替代療法。
rapid detection of beta-lactamases is crucial for guiding antibiotic stewardship programs.
快速檢測β-內醯胺酶對於指導抗生素管理方案至關重要。
carbapenemase beta-lactamases are particularly concerning due to their broad spectrum of activity.
碳青黴烯酶類β-內醯胺酶因其廣譜活性而特別令人擔憂。
researchers are developing novel inhibitors to overcome beta-lactamase resistance.
研究人員正在開發新型抑制劑以克服β-內醯胺酶的抗藥性。
the presence of extended-spectrum beta-lactamases (esbls) is a growing public health concern.
廣譜β-內醯胺酶（ESBLs）的存在正成為日益增長的公共衛生問題。
beta-lactamase genes are often located on mobile genetic elements, facilitating their spread.
β-內醯胺酶基因通常位於可移動的遺傳元件上，促進其傳播。
clinical laboratories routinely screen for beta-lactamases in bacterial isolates.
臨床實驗室通常會對細菌分離株進行β-內醯胺酶的篩查。
the increased incidence of beta-lactamase production necessitates new diagnostic approaches.
β-內醯胺酶產生的增加需要新的診斷方法。
understanding beta-lactamase mechanisms is essential for developing effective antibiotics.
了解β-內醯胺酶的機制對於開發有效的抗生素至關重要。
探索常見搜尋詞彙